| Cytoskeleton–membrane interactions in membrane raft structure GR Chichili, W Rodgers Cellular and molecular life sciences 66, 2319-2328, 2009 | 288 | 2009 |
| First-in-human phase 1 study of margetuximab (MGAH22), an Fc-modified chimeric monoclonal antibody, in patients with HER2-positive advanced solid tumors YJ Bang, G Giaccone, SA Im, DY Oh, TM Bauer, JL Nordstrom, H Li, ... Annals of Oncology 28 (4), 855-861, 2017 | 224 | 2017 |
| Targeting CD123 in acute myeloid leukemia using a T-cell–directed dual-affinity retargeting platform M Al-Hussaini, MP Rettig, JK Ritchey, D Karpova, GL Uy, LG Eissenberg, ... Blood, The Journal of the American Society of Hematology 127 (1), 122-131, 2016 | 190 | 2016 |
| A CD3xCD123 bispecific DART for redirecting host T cells to myelogenous leukemia: preclinical activity and safety in nonhuman primates GR Chichili, L Huang, H Li, S Burke, L He, Q Tang, L Jin, S Gorlatov, ... Science translational medicine 7 (289), 289ra82-289ra82, 2015 | 181 | 2015 |
| Clustering of membrane raft proteins by the actin cytoskeleton GR Chichili, W Rodgers Journal of Biological Chemistry 282 (50), 36682-36691, 2007 | 177 | 2007 |
| β-Carotene conversion into vitamin A in human retinal pigment epithelial cells GR Chichili, D Nohr, M Schäffer, J von Lintig, HK Biesalski Investigative ophthalmology & visual science 46 (10), 3562-3569, 2005 | 98 | 2005 |
| Conversion of β‐carotene to retinal pigment HK Biesalski, GR Chichili, J Frank, J Von Lintig, D Nohr Vitamins & hormones 75, 117-130, 2007 | 97 | 2007 |
| Development of PF-06671008, a highly potent anti-P-cadherin/anti-CD3 bispecific DART molecule with extended half-life for the treatment of cancer AR Root, W Cao, B Li, P LaPan, C Meade, J Sanford, M Jin, C O’Sullivan, ... Antibodies 5 (1), 6, 2016 | 94 | 2016 |
| Compartmentalization of phosphatidylinositol 4, 5-bisphosphate signaling evidenced using targeted phosphatases CM Johnson, GR Chichili, W Rodgers Journal of biological chemistry 283 (44), 29920-29928, 2008 | 92 | 2008 |
| Integrated pharmacokinetic/pharmacodynamic model of a bispecific CD3xCD123 DART molecule in nonhuman primates: evaluation of activity and impact of immunogenicity O Campagne, A Delmas, S Fouliard, M Chenel, GR Chichili, H Li, ... Clinical Cancer Research 24 (11), 2631-2641, 2018 | 63 | 2018 |
| Development of MGD007, a gpA33 x CD3-bispecific DART protein for T-cell immunotherapy of metastatic colorectal cancer PA Moore, K Shah, Y Yang, R Alderson, P Roberts, V Long, D Liu, JC Li, ... Molecular Cancer Therapeutics 17 (8), 1761-1772, 2018 | 62 | 2018 |
| Bi-specific monovalent diabodies that are capable of binding CD123 and CD3, and uses thereof E Bonvini, LS Johnson, L Huang, PA Moore, GR Chichili, RF Alderson US Patent 9,822,181, 2017 | 51 | 2017 |
| Protective effects of tomato extract with elevated β-carotene levels on oxidative stress in ARPE-19 cells GR Chichili, D Nohr, J Frank, A Flaccus, PD Fraser, EMA Enfissi, ... British journal of nutrition 96 (4), 643-649, 2006 | 51 | 2006 |
| Multiplex polymerase chain reaction for the detection of herpes simplex virus, varicella-zoster virus and cytomegalovirus in ocular specimens GR Chichili, S Athmanathan, S Farhatullah, N Gangopadhyay, S Jalali, ... Current eye research 27 (2), 85-90, 2003 | 51 | 2003 |
| T cell signal regulation by the actin cytoskeleton GR Chichili, AD Westmuckett, W Rodgers Journal of biological chemistry 285 (19), 14737-14746, 2010 | 43 | 2010 |
| Phase 1/2 study of a novel 24-valent pneumococcal vaccine in healthy adults aged 18 to 64 years and in older adults aged 65 to 85 years GR Chichili, R Smulders, V Santos, B Cywin, L Kovanda, C Van Sant, ... Vaccine 40 (31), 4190-4198, 2022 | 34 | 2022 |
| Early and dynamic polarization of T cell membrane rafts and constituents prior to TCR stop signals JS Van Komen, S Mishra, J Byrum, GR Chichili, JC Yaciuk, AD Farris, ... The Journal of Immunology 179 (10), 6845-6855, 2007 | 21 | 2007 |
| Isolation of coliphages specific to enterotoxigenic E. coli (ETEC) N Jothikumar, CG Reddy, RB Sundari, DVR Saigopal Journal of Environmental Monitoring 2 (4), 372-374, 2000 | 21 | 2000 |
| Targeting CD123 in leukemic stem cells using dual affinity re-targeting molecules (DARTs®) MHAL Hussaini, J Ritchey, MP Rettig, L Eissenberg, GL Uy, G Chichili, ... Blood 122 (21), 360, 2013 | 19 | 2013 |
| Tailoring CD19xCD3-DART exposure enhances T-cells to eradication of B-cell neoplasms P Circosta, AR Elia, I Landra, R Machiorlatti, M Todaro, S Aliberti, D Brusa, ... Oncoimmunology 7 (4), e1341032, 2018 | 15 | 2018 |
